Skip to main content

Latest News

26/01/2021
In review: AWMSG publishes Annual Report 2019-2020

In a new look All Wales Medicines Strategy Group (AWMSG) annual report, read an overview of 2019-2020 as AWMSG embarks on a new chapter.

31/12/2020
AWMSG hosts first virtual Open Day for Pharmaceutical Industry

The All Wales Medicines Strategy Group (AWMSG) team continue to adapt to a new way of working with the launch of a virtual Open Day programme for the pharmaceutical industry.

13/11/2020
New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for extending the use of a medicine.

23/10/2020
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for one medicine.

25/09/2020
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for three medicines.

17/09/2020
AWMSG supports World Patient Safety Day 2020

The All Wales Medicines Strategy Group (AWMSG) joins health care professionals across the world in supporting World Patient Safety Day 2020.

05/08/2020
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for three medicines.

06/07/2020
AWTTC expands educational remit with new collaboration

The All Wales Therapeutics and Toxicology Centre (AWTTC) has worked in conjunction with Health Education and Improvement Wales (HEIW) on a new module that launched in June.

30/06/2020
Positive review by AWMSG sees HIV prevention drug made routinely available in Wales

After a successful Welsh Government funded study, a pre-exposure prophylaxis HIV prevention drug combination will be routinely available to those eligible across Wales.

25/03/2020
Coronavirus (COVID-19) - therapeutic advice

AWTTC has compiled a series of resources for prescribers and patients to help with the appropriate use of medicines during the current pandemic. These can be accessed from the AWTTC COVID-19 Therapeutic Hub.

18/02/2020
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for two medicines, dolutegravir/lamivudine (Dovato®) and plerixafor (Mozobil®) 

20/12/2019
Presentation at 5th Annual Welsh Rare Disease Patient Network Meeting

The AWMSG process for appraising medicines used to treat rare conditions was outlined and the results from a review of the process were presented.

13/12/2019
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for two medicines, fampridine (Fampyra®) and glycerol phenylbutyrate (Ravicti®). 

03/12/2019
New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for four new medicines, cefepime dihydrochloride monohydrate (Renapime®), diamorphine hydrochloride (Ayendi®), dupilumab (Dupixent®) and melatonin (Slenyto®).

25/10/2019
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for two medicines zanamivir (Dectova®) and glecaprevir/pibrentasvir (Maviret®). 

25/07/2019
New Chair appointed to All Wales Medicines Strategy Group

Health Minister, Vaughan Gething has today (Thursday 25 July) announced the appointment of Professor Ceri Phillips as the new Chair of the All Wales Medicines Strategy Group (AWMSG) for a four year period.